IMAX Corporation (NYSE:IMAX – Get Free Report) CEO Richard Gelfond sold 15,746 shares of IMAX stock in a transaction on Wednesday, April 15th. The stock was sold at an average price of $37.07, for a total transaction of $583,704.22. Following the transaction, the chief executive officer directly owned 765,002 shares of the company’s stock, valued at $28,358,624.14. The trade was a 2.02% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
IMAX Stock Up 0.5%
NYSE IMAX opened at $37.03 on Thursday. The company has a fifty day moving average of $38.25 and a two-hundred day moving average of $36.14. The firm has a market capitalization of $2.00 billion, a price-to-earnings ratio of 59.72, a PEG ratio of 1.68 and a beta of 0.41. IMAX Corporation has a 52 week low of $21.49 and a 52 week high of $43.16.
IMAX (NYSE:IMAX – Get Free Report) last posted its quarterly earnings data on Wednesday, February 25th. The company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.43 by $0.15. The company had revenue of $125.21 million during the quarter, compared to analyst estimates of $120.30 million. IMAX had a net margin of 8.50% and a return on equity of 13.53%. IMAX’s quarterly revenue was up 35.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.27 earnings per share. Equities research analysts anticipate that IMAX Corporation will post 0.91 EPS for the current year.
Institutional Trading of IMAX
Analyst Ratings Changes
Several research analysts have commented on the stock. The Goldman Sachs Group lifted their price objective on shares of IMAX from $37.00 to $41.00 and gave the stock a “neutral” rating in a research note on Monday, March 2nd. Rosenblatt Securities reissued a “buy” rating and set a $47.00 target price on shares of IMAX in a research note on Tuesday, February 24th. Barrington Research reissued an “outperform” rating and set a $42.00 target price on shares of IMAX in a research note on Monday, January 26th. Macquarie Infrastructure boosted their target price on shares of IMAX from $39.00 to $44.00 and gave the company an “outperform” rating in a research note on Thursday, January 15th. Finally, JPMorgan Chase & Co. boosted their target price on shares of IMAX from $47.00 to $48.00 and gave the company an “overweight” rating in a research note on Thursday, February 26th. Ten analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $43.70.
Read Our Latest Analysis on IMAX
IMAX News Summary
Here are the key news stories impacting IMAX this week:
- Positive Sentiment: Filmmaker profile describing how a total solar eclipse was captured for IMAX 70mm, highlighting premium-format filmmaking that reinforces IMAX’s value proposition for event-driven, high-margin theatrical releases. Melted Film and a Dramatic Cross-Country Drive: How One Filmmaker Captured a Total Solar Eclipse for IMAX 70MM
- Positive Sentiment: News that “Project Hail Mary” is returning to IMAX for a one-week run — a direct box-office boost and reminder of recurring theatrical demand for blockbuster titles in IMAX auditoriums. “Project Hail Mary” to amaze in IMAX again for one week
- Positive Sentiment: Miami Grand Prix 2026 IMAX ticket sales announcement signals brand partnerships and experiential event opportunities that can drive ancillary revenue and marketing exposure for IMAX venues and premium experiences. Miami Grand Prix 2026 IMAX tickets now on sale: How much are they and how to get them?
- Negative Sentiment: CEO Richard Gelfond executed multiple share sales totaling over 100k shares across several days under a Rule 10b5-1 plan (largest sale ~97,462 shares). Large insider disposals can create short-term selling pressure or raise governance/optics concerns for some investors. SEC filing: insider sales
- Negative Sentiment: Zacks preview expresses caution ahead of IMAX’s upcoming earnings, suggesting the company may not have the setup for a beat — a research note that can temper expectations and cap upside until results. Imax (IMAX) Earnings Expected to Grow: Should You Buy?
IMAX Company Profile
IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.
Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.
Featured Stories
Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.
